BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22674302)

  • 41. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reciprocity in breast cancer progression.
    Gespach C
    Oncotarget; 2014 Nov; 5(22):10967-8. PubMed ID: 25526025
    [No Abstract]   [Full Text] [Related]  

  • 43. RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.
    Bozza WP; Zhang Y; Hallett K; Rivera Rosado LA; Zhang B
    Oncotarget; 2015 Oct; 6(32):32723-36. PubMed ID: 26416248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.
    Coumans JV; Gau D; Poljak A; Wasinger V; Roy P; Moens PD
    OMICS; 2014 Dec; 18(12):778-91. PubMed ID: 25454514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness.
    Zhang Y; Zhang B
    Cancer Res; 2006 Jun; 66(11):5592-8. PubMed ID: 16740694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.
    Schunke D; Span P; Ronneburg H; Dittmer A; Vetter M; Holzhausen HJ; Kantelhardt E; Krenkel S; Müller V; Sweep FC; Thomssen C; Dittmer J
    Cancer Res; 2007 Nov; 67(22):10694-702. PubMed ID: 18006811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion.
    Nakata Y; Kondoh K; Fukushima S; Hashiguchi A; Du W; Hayashi M; Fujimoto J; Hata J; Yamada T
    Exp Hematol; 2008 Jan; 36(1):37-50. PubMed ID: 18037226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.
    Zhang Y; Rivera Rosado LA; Moon SY; Zhang B
    J Biol Chem; 2009 May; 284(19):12956-65. PubMed ID: 19269969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of D4-GDI expression with breast cancer progression.
    Rivera Rosado LA; Rodriguez-Canales J; Zhang B
    Cancer Biomark; 2011-2012; 10(3-4):163-73. PubMed ID: 22674302
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.